Cited by 62Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementDiabetes Management and Research

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Early‐onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes—Results from the DD2 study

Open access

Abstract

Aim: To examine the association between early onset of type 2 diabetes mellitus (DM) and clinical and behavioural risk factors for later complications of diabetes. Methods: We conducted a cross‐sectional study of 5115 persons with incident type 2 DM enrolled during 2010‐2015 in the Danish Centre for Strategic Research in Type 2 Diabetes‐cohort. We compared risk factors at time of diagnosis among those diagnosed at ≤45 years (early onset) with diagnosis age 46 to 55, 56 to 65 (average onset = reference), 66 to 75, and >75 years (late onset). Prevalence ratios (PRs) were computed by using Poisson regression. Results: Poor glucose control, ie, HbA1c ≥ 75 mmol/mol (≥9.0%) in the early‐, average‐, and late‐onset groups was observed in 12%, 7%, and 1%, respectively (PR 1.70 [95% confidence intervals (CI) 1.27, 2.28] and PR 0.17 [95% CI 0.06, 0.45]). A similar age gradient was observed for severe obesity (body mass index > 40 kg/m 2: 19% vs. 8% vs. 2%; PR 2.41 [95% CI 1.83, 3.18] and 0.21 (95% CI 0.08, 0.57]), dyslipidemia (90% vs. 79% vs. 68%; PR 1.14 [95% CI 1.10, 1.19] and 0.86 [95% CI 0.79, 0.93]), and low‐grade inflammation (C‐reactive protein > 3.0 mg/L: 53% vs. 38% vs. 26%; PR 1.41 [95% CI 1.12, 1.78] and 0.68 [95% CI 0.42, 1.11]). Daily smoking was more frequent and meeting physical activity recommendations less likely in persons with early‐onset type 2 DM. Conclusions: We found a clear age gradient, with increasing prevalence of clinical and behavioural risk factors the younger the onset age of type 2 DM. Younger persons with early‐onset type 2 DM need clinical awareness and support.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dmrr.2968

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Bo, A., Thomsen, R. W., Nielsen, J. S., Nicolaisen, S. K., Beck‐Nielsen, H., Rungby, J., Sørensen, H. T., Hansen, T. K., Søndergaard, J., Friborg, S., Lauritzen, T., & Maindal, H. T.
Affiliations
  • Aarhus University (DK)
  • Aarhus University Hospital (DK)
  • Odense University Hospital (DK)
  • University of Southern Denmark (DK)
Corresponding author
Bo, A.
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2017-12-21
Volume
34
Issue
3
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W2769678239
Cited by
62
References
32
Citations by year
2026: 9 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 4
FWCI
2.81
Type
journal article
Language
en
Open access
Locations
  • Diabetes/Metabolism Research and Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, other-oa)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Scopus (Elsevier) (submittedVersion)
Funders
  • Aarhus Universitet
  • Riisfort Fonden
  • Sundhedsstyrelsen
  • Styrelsen for Forskning og Innovation (09‐067009, 09‐075724)
  • Novo Nordisk UK Research Foundation
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
early-onset type 2 diabetes, age at diagnosis, diabetes risk factors, HbA1c, glycemic control, morbid obesity, dyslipidemia, low-grade inflammation, C-reactive protein, smoking, physical activity, diabetes complications
MeSH terms
Age Factors, Aged, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Risk Factors, Body Mass Index, Age of Onset

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review